DWEK: A New Treatment for Fuchs’ Endothelial Dystrophy
Provider: Mivision
Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616
Learning Objectives
- 1. Understand that Fuch’s Endothelial Dystrophy is the commonest cause of endothelial failure and there are potential new treatment strategies for this.
- 2.Understand the difference between endothelial keratoplasties: Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) versus Descemet’s Membrane Endothelial Keratoplasty (DMEK)
- 3.Understand that there is a new technique called DWEK/DSO, which does not involve a corneal transplant and that this is a very promising technique that we are currently recruiting for clinical trials.
Max points awarded: 2.00
Session Information
| Name |
|---|
| DWEK: A New Treatment for Fuchs’ Endothelial Dystrophy |
| Activity Type |
| Independent Learning with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |
